Feedback / Questions
camoteskimab (AVTX-007) - Apollo Therap
https://www.apollotx.com/news/apollo-therapeutics-anti-il-18-antibody-camoteskimab-met-the-primary-endpoint/
Sep 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next